News | April 25, 2022
Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
